Miracor Medical Systems has successfully completed the pilot study of PICSO System, which is designed to improve acute coronary syndrome (ACS) revascularisation following primary percutaneous coronary intervention (PCI).
Miracor Medical Systems said that the PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion system) system consists of the Miracor Picso Impulse Console and the disposable, single-use Miracor Picso Impulse Catheter.
The study involved ten patients with stable angina and was conducted in at the Academic Medical Center, Amsterdam, The Netherlands.
In the study, the PICSO catheter was safely inserted into the coronary sinus in all the patients and there was a notable reduction of ischemia as documented by the surface ECG ST-segment shift in several patients.
Following the positive results, Miracor is planning to initiate a pivotal clinical trial of PICSO System in 2011.